AGA Clinical Guidelines on Management of Eosinophilic Esophagitis: Accompanying Educational Presentation
Overview
AGA and the Joint Task Force on Allergy-Immunology Practice Parameters release guideline on the management of eosinophilic esophagitis (EoE). This guideline provides evidence-based recommendations for allergists and gastroenterologists focusing on the clinical management of EoE for pediatric and adult patients.
Learning objectives
- Understand that topical steroids are recommended as a first-line treatment for EoE.
- Explain proton pump inhibition (PPI) therapy, diet therapy and esophageal dilation as treatment options.
- Understand that the use of novel, targeted biologic therapies for EoE are being actively evaluated and more research is needed before these can be recommended.
Key dates
- Released date:
- May 31, 2020
- Expiration date:
- Jun 1, 2027
Pricing
Agenda
All times are Eastern.
Session Heading 1: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Session Heading 2: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Course contents
Video
14 mins
Course faculty
Faculty
Ikuo Hirano, MD, AGAF
Division of Gastroenterology and Hepatology Northwestern University Feinberg School of Medicine Chicago, Illinois
Glenn Furuta, MD, AGAF
Professor, Pediatrics-Gastroenterology, Hepatology and Nutrition Director, Gastrointestinal Eosinophilic Diseases Program Aurora, Colorado